Landmark Study Shows Important Benefits Of Seretide™ Treatment For Patients With Fatal Lung Disease, COPD
Fri, 23 Feb 2007 07:00 PM EST
... Results of the TOwards a Revolution in COPD Health (TORCH) study, the largest of its kind have been published today in the New England Journal of Medicine1 and represent a landmark in COPD, a disease which kills more people each year than breast cancer and lung cancer combined.2,3 The results show important benefits of Seretide in the treatment of patients with COPD. [click link for full article] ...
Related Topics
- Lung Diseases & Disorders
- Respiratory Diseases
- Chronic Diseases
- Emphysema
- Black Lung
- Lung Cancer
- Insomnia
- COPD (Chronic Obstructive Pulmonary Disease)
- Small Cell Lung Cancer
- Diseases & Conditions
- Cardiovascular Diseases And Disorders
- Fungal Diseases
- Rare Diseases
- Chronic Obstructive Pulmonary Disease
- Periodontal Disease
- Chronic Obstructive Pulmonary Disease (COPD)
- Vascular Disease
- Addison's Disease
- CHF
- Heart Disease

Not Signed In -


